Trivaris Side Effects
Generic name: triamcinolone ophthalmic
Medically reviewed by Drugs.com. Last updated on Sep 26, 2022.
Note: This document contains side effect information about triamcinolone ophthalmic. Some dosage forms listed on this page may not apply to the brand name Trivaris.
Applies to triamcinolone ophthalmic: intraocular suspension.
Serious side effects of Trivaris
Along with its needed effects, triamcinolone ophthalmic (the active ingredient contained in Trivaris) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking triamcinolone ophthalmic:
- blurred vision
- change in vision
- eye pain
- increased pressure in the eye
- loss of vision
- seeing flashes or sparks of light
- seeing floating spots before the eyes, or a veil or curtain appearing across part of vision
- Bloody eye
- change in color vision
- difficulty seeing at night
- drooping upper eyelids
- increased sensitivity of the eyes to sunlight
- painful irritation of the clear front part of the eye
- swelling or redness of the eye or inside of the eyelids
Incidence not known
- darkening of the skin
- dry mouth
- facial hair growth in females
- flushed, dry skin
- fruit-like breath odor
- full or round face, neck, or trunk
- increased hunger
- increased thirst or urination
- loss of appetite
- loss of sexual desire or ability
- menstrual irregularities
- mental depression
- muscle wasting
- trouble breathing
- unexplained weight loss
- unusual tiredness or weakness
Other side effects of Trivaris
Some side effects of triamcinolone ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
For Healthcare Professionals
Applies to triamcinolone ophthalmic: intraocular suspension, intravitreal suspension.
Frequency not reported: Endophthalmitis (infectious and non-infectious), hypopyon, injection site reactions (described as blurring and transient discomfort), glaucoma, vitreous floaters, detachment of retinal pigment epithelium, optic disc vascular disorder, eye inflammation, conjunctival hemorrhage, visual acuity reduced, exophthalmos[Ref]
Frequency not reported: Elevation in blood pressure, bradycardia, cardiac arrest, cardiac arrhythmia, cardiac enlargement, circulatory collapse, congestive heart failure, fat embolism, hypertrophic cardiomyopathy in premature infants, myocardial rupture following recent myocardial infarction, syncope, tachycardia, thromboembolism, thrombophlebitis, vasculitis[Ref]
Frequency not reported: Acne, allergic dermatitis, cutaneous and subcutaneous atrophy, dry scalp, edema, facial erythema, hyper or hypopigmentation, increased sweating, petechiae, ecchymosis, rash, sterile abscess, striae, suppressed reactions to skin tests, thin fragile skin, thinning scalp hair, urticaria[Ref]
Frequency not reported: Alteration in glucose tolerance, abnormal fat deposits, decreased carbohydrate tolerance, development of Cushingoid state, hirsutism, manifestations of latent diabetes mellitus and increased requirements for insulin or oral hypoglycemic agents in diabetics, menstrual irregularities, moon facies, secondary adrenocortical and pituitary unresponsiveness (particularly in times of stress, as in trauma, surgery or illness), suppression of growth in children[Ref]
Frequency not reported: Fluid retention, increased appetite, weight gain, potassium loss, hypokalemic alkalosis, negative nitrogen balance due to protein catabolism[Ref]
Frequency not reported: Aseptic necrosis of femoral and humeral heads, Charcot-like arthropathy, loss of muscle mass, muscle weakness, osteoporosis, pathologic fracture of long bones, steroid myopathy, tendon rupture, vertebral compression fractures[Ref]
Frequency not reported: Arachnoiditis, convulsions, headache, increased intracranial pressure with papilledema (pseudo-tumor cerebri) usually following discontinuation of treatment, insomnia, meningitis, neuritis, neuropathy, paraparesis/paraplegia, paresthesia, sensory disturbances, vertigo[Ref]
Postmarketing reports: Alteration in motility and number of spermatozoa[Ref]
Frequency not reported: Elevation in serum liver enzymes levels (usually reversible upon discontinuation), hepatomegaly[Ref]
Frequency not reported: Impaired wound healing[Ref]
Frequency not reported: Behavioral and mood changes, depression, emotional instability, euphoria[Ref]
More about Trivaris (triamcinolone ophthalmic)
- Check interactions
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: ophthalmic steroids
Related treatment guides
1. "Product Information. Triesence (triamcinolone ophthalmic)." Alcon Laboratories Inc (2007):
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.